Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 3012

BillFederalHouseIn Committee
Right to Try Act of 2015
About This Bill
Committee
Latest Action · July 29, 2015
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Congress
114th (2015–2017)
Introduced
July 9, 2015
Cosponsors (61)
9D 52R
View PDF ↗

Summary

Highlight any text to annotate
Right to Try Act of 2015 Bars the federal government from prohibiting or restricting the production, manufacture, distribution, prescribing, dispensing, possession, or use of an experimental drug, biological product, or device that is: (1) intended to treat a patient who has been diagnosed with a terminal illness; and (2) authorized by, and in accordance with, state law. Defines an "experimental drug, biological product, or device" as one that: (1) has successfully completed a phase 1 clinical investigation; (2) remains under investigation in a clinical trial approved by the Food and Drug Administration; and (3) is not approved, licensed, or cleared for commercial distribution under the Federal Food, Drug, or Cosmetic Act or the Public Health Service Act.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.